4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001179110-20-004006
Options or other derivatives
- Director acquired 3,789 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Saad Mark E Director | 2020-03-17 | Grant or award · Stock Option (Right to Buy) | +3,789 | 3,789 | D: show line 1 in the form |
Loading xslF345X03/edgar.xml…